Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.96% | -2.90% | -2.83% | -0.76% | 1.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.96% | -2.90% | -2.83% | -0.76% | 1.37% |
| Cost of Revenue | -1.26% | -3.27% | -5.25% | -5.00% | -4.75% |
| Gross Profit | -4.02% | -2.66% | -1.30% | 2.05% | 5.59% |
| SG&A Expenses | 0.43% | 1.96% | 3.54% | 9.77% | 16.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 19.68% | 51.27% | 97.87% | 55.23% | 20.43% |
| Total Operating Expenses | -0.26% | -0.11% | 0.05% | 2.57% | 5.19% |
| Operating Income | -30.69% | -28.79% | -27.22% | -26.69% | -26.22% |
| Income Before Tax | -4.86% | -8.94% | -12.36% | -19.45% | -25.73% |
| Income Tax Expenses | 32.97% | 9.92% | -10.80% | -2.81% | 6.67% |
| Earnings from Continuing Operations | -10.13% | -11.46% | -12.56% | -21.27% | -28.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.94% | -47.00% | -160.19% | -475.37% | -3,461.61% |
| Net Income | -12.53% | -16.94% | -20.23% | -30.41% | -38.74% |
| EBIT | -30.69% | -28.79% | -27.22% | -26.69% | -26.22% |
| EBITDA | -22.61% | -20.23% | -18.08% | -17.20% | -16.38% |
| EPS Basic | -12.70% | -17.15% | -20.47% | -30.57% | -38.83% |
| Normalized Basic EPS | -23.95% | -30.75% | -35.62% | -38.45% | -40.78% |
| EPS Diluted | -13.10% | -17.18% | -20.36% | -30.48% | -38.76% |
| Normalized Diluted EPS | -23.95% | -30.58% | -35.34% | -38.21% | -40.57% |
| Average Basic Shares Outstanding | 0.10% | 0.15% | 0.21% | 0.22% | 0.23% |
| Average Diluted Shares Outstanding | 0.09% | 0.05% | 0.00% | -0.01% | -0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.03% | 0.08% | 0.13% | 0.45% | 0.84% |